Search for: "ESSENTIAL PHARMACEUTICALS, LLC" Results 21 - 40 of 196
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2021, 1:56 pm by Joe Mullin
Just a tiny slice of universities earn the majority of patent-licensing revenue, often from a few blockbuster pharmaceutical or biotech inventions. [read post]
28 Apr 2021, 2:02 am by Deb Givens
The court, essentially, tossed out a practice that the FTC has used since the 1980s. [read post]
27 Jan 2021, 11:22 am by anne
After Ameriprise discovered her misconduct and fired her, Hsu founded American Capital Trading Group LLC and American Capital Republic, Inc., where she sought out and defrauded additional investors. [read post]
10 Aug 2020, 9:38 am by David Gallacher and Keeley A. McCarty
” Here is the two-part definition: The Critical Inputs, which includes the active pharmaceutical ingredients (API), used to produce the “Essential Medicines” or “Medical Countermeasures” must be produced in the United States; and The finished drug or device must be manufactured, prepared, propagated, compounded, or processed in the United States. [read post]
15 May 2020, 2:52 pm by luiza
” As for “treatments,” Oklahoma company Xephyr LLC, doing business as N-Ergetics, and its owners Brad Brand, Derill J. [read post]
4 May 2020, 4:26 pm by Brittany Walter and Steven Hollman
Biotechnology and pharmaceutical companies devote substantial sums of money to research and development (“R&D”). [read post]
13 Apr 2020, 4:19 pm by Kevin LaCroix
  Data science is essential for a verifiably transparent and efficient delivery of justice in securities class action settlement proceedings. [read post]
22 Mar 2020, 5:42 am by Magdaleen Jooste
The photographs are the copyright of Swedishandstylish LLC. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Making sure essential products remain available. [read post]
16 Mar 2020, 1:54 pm by Kevin LaCroix
In the following guest post, Dan Gold, Thad Behrens, Kit Adelman, and Emily Westridge Black of the Haynes and Boone, LLP law firm review the key developments during 2019 in securities litigation and enforcement, including significant securities related decisions by the Supreme Court and federal appellate courts, key developments in SEC enforcement, and significant rulings in state law fiduciary litigation against directors and officers of public companies. [read post]